Kyowa Kirin is continuing to monitor the COVID-19 outbreak. Learn More

Dosing schedule1

  • Administer POTELIGEO until disease progression or unacceptable toxicity
  • The recommended dose of POTELIGEO is 1 mg/kg administered as an intravenous infusion over at least 1 hour
  • Administer on days 1, 8, 15, and 22 of the first 28-day cycle, then on days 1 and 15 of each subsequent 28-day cycle
Table of Poteligeo dosing schedule

Missed doses

  • If the dose is administered within 2 days of these scheduled doses, continue original schedule
  • If the scheduled dose is missed by more than 2 days, administer the missed dose as soon as possible and resume dosing schedule
Table of recommended premedications for patients taking Poteligeo

For more information on dosing, see the POTELIGEO Dosing and Administration Guide

POTELIGEO is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy.

Important Safety Information